AzTrials
AzTrials

MRINCT04735276

MRI Study of the Gastric Insufflation After High-flow Nasal Oxygen (HFNO)

An observational study of MRI, run by University of Liege.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

HFNO CAN BE USED AS A PREOXYGENATION TECHNIQUE BUT IS IT A SAFE TECHNIQUE IN TERMS OF GASTRIC INSUFFLATION? Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
MRI
What is being tested?
HFNO for 5 min
Type of treatment
Medical device
How many people
30 participants
Where
No sites listed yet
Study dates
1 Apr 2021to 30 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: healthy adult volunteers

Who may be able to join

  • Adults Volunteers

Who cannot join

  • Pregnancy
  • Claustrophobia
  • Gastric surgery
  • Gastric pathology

Trial locations and contacts

No sites are listed yet.

Benjamin Javillier, MD contact

003243667180

javillier.benjamin@hotmail.com

About this study

HFNO CAN BE USED AS A PREOXYGENATION TECHNIQUE BUT IS IT A SAFE TECHNIQUE IN TERMS OF GASTRIC INSUFFLATION?

Read the detailed description

The objective of this study is to evaluate by MRI whether the stomach is insufflated during HFNO use in healthy volunteers.

Conditions
MRI
Being tested
HFNO for 5 min

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HFNO for 5 minDevice

    1st basic MRI then HFNO for 5 min with mouth closed breathing and 2nd MRI. Analysis of the surface of the gastric antrum.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the antero-posterior and cranio-caudal diameters of the gastric antrum

    surface of the gastric antrum

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2021
  2. Study start1 Apr 2021 (estimated)
  3. Primary completion30 May 2021 (estimated)
  4. Study completion30 Aug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04735276
Sponsor's protocol ID
Optirm
Status last verified
Jan 2021
First submitted
25 Jan 2021
Last updated
3 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of MRI, run by University of Liege.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Benjamin Javillier, MD (003243667180, javillier.benjamin@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the antero-posterior and cranio-caudal diameters of the gastric antrum (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in